Investors Tire of A...
Health Care: Drugs
Amarin Corporation PLC (AMRN: NASDAQ)
$8.62 -0.02 | -0.23%
02/09/12 - 04:00 PM ET
1.88M / 2.74M
Vol / Avg. Vol:8.68 / 8.64
Open / Prev. Close:8.33 - 8.71
Today's Range:5.99 - 19.87
52 Wk Range:15.35%
Performance YTD:TheStreet Rating:
Portfolios with AMRN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Biotech Stocks Loved and...
- Contributor11 Biotech Stocks Loved or ...
- ContributorBreakout Stocks Of The Week...
- Contributor5 Drug Stock Winners of 2010
- UserSUPRATRADE-Top-Performing C...
- UserSUPRATRADE-2205101129
- UserSpeculative Appreciation
- Userbmarsc3529 Portfolio 1
- UserBotchlerstone
Latest AMRN Headlines from TheStreet
- Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- J.P. Morgan Biotech Confab Live Chat 01.09.12 | 07:01 pm
- Amarin CEO Seeks Redemption And Investors at JP Morgan Conference 01.09.12 | 03:01 pm
- Friday's Top 10 Articles, Videos 01.06.12 | 01:01 pm
- Biotech Stock Mailbag: Amarin, Spectrum, Arena 01.06.12 | 06:01 am
- Acme Packet, TiVo: After-Hours Trading 01.03.12 | 05:01 pm
- Your Vote Counts: Who is the Worst Biotech CEO of 2011? 12.01.11 | 10:12 am
- 22 Hot Drugs Facing FDA Approval in 2012 11.29.11 | 08:11 am
- InterOil, Green Dot, Amarin Are Big Market Movers 11.25.11 | 05:11 pm
- 4 Stocks Under $10 With Big Upside Potential 11.25.11 | 12:11 pm
Press Releases for AMRN
- Amarin To Present At The Deutsche Bank 26th Annual Healthcare Conference - PR Newswire 04.26.11 | 08:04 am
- Amarin's AMR101 Phase 3 ANCHOR Trial Meets All Primary And Secondary Endpoints With Statistically Significant Reductions In Triglycerides At Both 4 Gram And 2 Gram Doses And Statistically Significant Decrease In LDL-C - PR Newswire 04.18.11 | 02:04 am
- Phase 3 MARINE Trial Data To Be Presented In May At The National Lipid Association 2011 Annual Scientific Sessions - PR Newswire 04.05.11 | 08:04 am
- Amarin To Present At The 10th Annual Needham Healthcare Conference - PR Newswire 03.31.11 | 07:03 am
Partner Headlines for AMRN
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Who Is Mad At Amarin? - Seeking Alpha 01.13.12 | 08:01 am
- Benzinga's M&A Chatter for Tuesday December 6, 2011 - Benzinga 12.06.11 | 04:12 pm
- Company News for November 28, 2011 - Corporate Summary - Zacks 11.28.11 | 10:11 am
- Mid-Day Update: Stocks Sitting Higher in Black Friday Rally; Europe Concern Lingers - NASDAQ 11.25.11 | 04:11 pm
- Friday Options Recap - Seeking Alpha 11.25.11 | 12:11 pm
- Cramer's Lightning Round - Ford Is Stalled (11/18/11) - Seeking Alpha 11.20.11 | 07:11 am
- Last Week's Institutional 5% Ownership Filings By Leading Funds - Seeking Alpha 10.25.11 | 09:10 am
- Healthcare Stocks To Watch This Week - Seeking Alpha 10.12.11 | 08:10 am
- Emisphere: Crown Jewel In Oral B12 - Seeking Alpha 10.07.11 | 09:10 am
